Association between a 46-SNP Polygenic Risk Score and melanoma risk in Dutch patients with familial melanoma

Background Familial clustering of melanoma suggests a shared genetic predisposition among family members, but only 10%–40% of familial cases carry a pathogenic variant in a known high-risk melanoma susceptibility gene. We investigated whether a melanoma-specific Polygenic Risk Score (PRS) is associated with melanoma risk in patients with genetically unexplained familial melanoma. Methods Dutch familial melanoma cases (n=418) were genotyped for 46 SNPs previously identified as independently associated with melanoma risk. The 46-SNP PRS was calculated and standardised to 3423 healthy controls (sPRS) and the association between PRS and melanoma risk was modelled using logistic regression. Within the case series, possible differences were further explored by investigating the PRS in relation to (1) the number of primary melanomas in a patient and (2) the extent of familial clustering of melanoma. Results The PRS was significantly associated with melanoma risk, with a per-SD OR of 2.12 (95% CI 1.90 to 2.35, p<0.001), corresponding to a 5.70-fold increased risk (95% CI 3.93 to 8.28) when comparing the top 90th to the middle 40–60th PRS percentiles. The mean PRS was significantly higher in cases with multiple primary melanomas than in cases with a single melanoma (sPRS 1.17 vs 0.71, p=0.001). Conversely, cases from high-density melanoma families had a lower (but non-significant) mean PRS than cases from low-density families (sPRS 0.60 vs 0.94, p=0.204). Conclusion Our work underlines the significance of a PRS in determining melanoma susceptibility and encourages further exploration of the diagnostic value of a PRS in genetically unexplained melanoma families.

[1]  A. Toland,et al.  Genome‐wide association studies and polygenic risk scores for skin cancer: clinically useful yet? , 2019, The British journal of dermatology.

[2]  A. Hollestelle,et al.  Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-BRCA1/2 breast cancer families , 2019, Journal of Medical Genetics.

[3]  C. V. van Asperen,et al.  Multigene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non‐CDKN2A/CDK4 melanoma families , 2019, International journal of cancer.

[4]  K. Brown,et al.  Assessing the Incremental Contribution of Common Genomic Variants to Melanoma Risk Prediction in Two Population-Based Studies , 2018, The Journal of investigative dermatology.

[5]  E. Topol,et al.  The personal and clinical utility of polygenic risk scores , 2018, Nature Reviews Genetics.

[6]  X. Hua,et al.  Combining common genetic variants and non‐genetic risk factors to predict risk of cutaneous melanoma , 2018, Human molecular genetics.

[7]  T. Assimes,et al.  Melanoma risk prediction using a multilocus genetic risk score in the Women's Health Initiative cohort , 2018, Journal of the American Academy of Dermatology.

[8]  A. Gavin,et al.  Trends in incidence of thick, thin and in situ melanoma in Europe. , 2018, European journal of cancer.

[9]  Jennifer D. Brooks,et al.  Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study , 2017, Journal of the National Cancer Institute.

[10]  L. Kiemeney,et al.  Cohort Profile Cohort Profile : The Nijmegen Biomedical Study ( NBS ) , 2017 .

[11]  B. Karlan,et al.  Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers , 2017, Journal of the National Cancer Institute.

[12]  L. Thomas,et al.  Genetic Testing for Melanoma-Where Are We With Moderate-Penetrance Genes? , 2016, JAMA dermatology.

[13]  E. M. Warton,et al.  Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011. , 2015, Journal of the American Academy of Dermatology.

[14]  N. Hayward,et al.  Melanoma genetics , 2015, Journal of Medical Genetics.

[15]  Marko Hočevar,et al.  Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma , 2015, Nature Genetics.

[16]  A. Gerdes,et al.  High accuracy of family history of melanoma in Danish melanoma cases , 2015, Familial Cancer.

[17]  N. Hayward,et al.  Molecular Characterization of Melanoma Cases in Denmark Suspected of Genetic Predisposition , 2015, PloS one.

[18]  N. Hayward,et al.  Genetics of familial melanoma: 20 years after CDKN2A , 2015, Pigment cell & melanoma research.

[19]  S. Puig,et al.  Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions , 2014, International journal of cancer.

[20]  K. Glanz,et al.  Effects of Tailored Risk Communications for Skin Cancer Prevention and Detection: The PennSCAPE Randomized Trial , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[21]  C. Bertolotto,et al.  A germline oncogenic MITF mutation and tumor susceptibility. , 2014, European journal of cell biology.

[22]  J. Lortet-Tieulent,et al.  International trends in the incidence of malignant melanoma 1953–2008—are recent generations at higher or lower risk? , 2013, International journal of cancer.

[23]  D. Bowtell,et al.  A role for common genomic variants in the assessment of familial breast cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  N. Hayward,et al.  Melanoma genetics: recent findings take us beyond well-traveled pathways. , 2012, The Journal of investigative dermatology.

[25]  Jeffrey E. Lee,et al.  Genome-wide association study identifies three new melanoma susceptibility loci , 2011, Nature Genetics.

[26]  S. Puig,et al.  Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study , 2010, Journal of the National Cancer Institute.

[27]  K. Peris,et al.  MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis. , 2010, European journal of cancer.

[28]  Nicholas G Martin,et al.  A population-based study of Australian twins with melanoma suggests a strong genetic contribution to liability. , 2009, The Journal of investigative dermatology.

[29]  J. Malvehy,et al.  Genome-wide association study identifies three loci associated with melanoma risk , 2009, Nature Genetics.

[30]  J. Lundeberg,et al.  MC1R variation and melanoma risk in the Swedish population in relation to clinical and pathological parameters , 2009, Pigment cell & melanoma research.

[31]  V. Bataille,et al.  Melanoma—Part 1: epidemiology, risk factors, and prevention , 2008, BMJ : British Medical Journal.

[32]  F. Sera,et al.  MC1R variants, melanoma and red hair color phenotype: A meta‐analysis , 2008, International journal of cancer.

[33]  S. Puig,et al.  High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. , 2006, Cancer research.

[34]  P. Boyle,et al.  Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. , 2005, European journal of cancer.

[35]  P. Boyle,et al.  Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. , 2005, European journal of cancer.

[36]  P. Boyle,et al.  Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. , 2005, European journal of cancer.